| Dr Bradford James Matthews, MD | |
|
8700 Stony Point Pkwy Ste 120, Richmond, VA 23235-1965 | |
| (804) 323-5011 | |
| Not Available |
| Full Name | Dr Bradford James Matthews |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 35 Years |
| Location | 8700 Stony Point Pkwy Ste 120, Richmond, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104847623 | NPI | - | NPPES |
| 440261 | Other | VA | ANTHEM/VA HEALTHKEEPERS |
| 47546 | Other | VA | SENTARA HEALTH/OPTIMA |
| 5851971 | Medicaid | VA | |
| 60061531 | Other | VA | RAILROAD MEDICARE |
| 939829 | Other | VA | MAMSI |
| 595137 | Other | VA | AETNA/US HEALTHCARE HMO |
| 27413300 | Other | VA | FEDERAL BLACK LUNG |
| 276358 | Other | VA | ANTHEM/VA HEALTHKEEPERS |
| 128173 | Other | VA | SOUTHERN HEALTH SERVICES |
| 276252 | Other | VA | ANTHEM/VA HEALTHKEEPERS |
| 276275 | Other | VA | ANTHEM/VA HEALTHKEEPERS |
| 1450771 | Other | VA | CIGNA |
| 276300 | Other | VA | ANTHEM/VA HEALTHKEEPERS |
| 276203 | Other | VA | ANTHEM/VA HEALTHKEEPERS |
| 4469323 | Other | VA | AETNA/US HEALTHCARE |
| 103785 | Other | VA | ANTHEM/VA HEALTHKEEPERS |
| 178957 | Other | VA | ANTHEM/VA HEALTHKEEPERS |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cjw Medical Center | Richmond, VA | Hospital |
| John Randolph Medical Center | Hopewell, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virginia Cardiovascular Specialists | 8921092826 | 50 |
| Chippenham And Johnston-willis Hospitals, Inc. | 9032105010 | 21 |
News Archive
An interest in solving complex problems, friends training to be medical doctors and his father having a stroke helped put John Asiruwa on the path to becoming a biomedical engineer.
Scientific research published in the current issue of the Journal of the American Medical Informatics Association (JAMIA) reports on a study of genetic variants that influence human susceptibility to peripheral arterial disease (PAD), made possible by leveraging electronic medical records (EMRs; also called EHRs or electronic health records).
Quest Diagnostics Incorporated, the world's leading cancer diagnostics company, today announced that its ColoVantage test has been approved by New York State's Department of Health for testing on samples of patients in the state. It is believed to be the first molecular colorectal cancer detection method that employs a venal blood specimen to be approved by the state.
A new DNA test may make it much simpler to identify patients at risk of malignant hyperthermia (MH)—a rare but life-threatening complication of exposure to common anesthetics reports the November issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
New research published in the Journal of Analytical Toxicology shows how fingerprint-based drug screening can not only screen for the presence, or absence, of four classes of drugs of abuse, but that the technology also works when used by UK coroners to detect drugs in the sweat of fingerprint samples gathered from deceased individuals.
› Verified 9 days ago
| Entity Name | Virginia Cardiovascular Specialists |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215958657 PECOS PAC ID: 8921092826 Enrollment ID: O20040413001221 |
News Archive
An interest in solving complex problems, friends training to be medical doctors and his father having a stroke helped put John Asiruwa on the path to becoming a biomedical engineer.
Scientific research published in the current issue of the Journal of the American Medical Informatics Association (JAMIA) reports on a study of genetic variants that influence human susceptibility to peripheral arterial disease (PAD), made possible by leveraging electronic medical records (EMRs; also called EHRs or electronic health records).
Quest Diagnostics Incorporated, the world's leading cancer diagnostics company, today announced that its ColoVantage test has been approved by New York State's Department of Health for testing on samples of patients in the state. It is believed to be the first molecular colorectal cancer detection method that employs a venal blood specimen to be approved by the state.
A new DNA test may make it much simpler to identify patients at risk of malignant hyperthermia (MH)—a rare but life-threatening complication of exposure to common anesthetics reports the November issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
New research published in the Journal of Analytical Toxicology shows how fingerprint-based drug screening can not only screen for the presence, or absence, of four classes of drugs of abuse, but that the technology also works when used by UK coroners to detect drugs in the sweat of fingerprint samples gathered from deceased individuals.
› Verified 9 days ago
| Entity Name | Chippenham & Johnston-willis Hospitals, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366689747 PECOS PAC ID: 9032105010 Enrollment ID: O20040831000405 |
News Archive
An interest in solving complex problems, friends training to be medical doctors and his father having a stroke helped put John Asiruwa on the path to becoming a biomedical engineer.
Scientific research published in the current issue of the Journal of the American Medical Informatics Association (JAMIA) reports on a study of genetic variants that influence human susceptibility to peripheral arterial disease (PAD), made possible by leveraging electronic medical records (EMRs; also called EHRs or electronic health records).
Quest Diagnostics Incorporated, the world's leading cancer diagnostics company, today announced that its ColoVantage test has been approved by New York State's Department of Health for testing on samples of patients in the state. It is believed to be the first molecular colorectal cancer detection method that employs a venal blood specimen to be approved by the state.
A new DNA test may make it much simpler to identify patients at risk of malignant hyperthermia (MH)—a rare but life-threatening complication of exposure to common anesthetics reports the November issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
New research published in the Journal of Analytical Toxicology shows how fingerprint-based drug screening can not only screen for the presence, or absence, of four classes of drugs of abuse, but that the technology also works when used by UK coroners to detect drugs in the sweat of fingerprint samples gathered from deceased individuals.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bradford James Matthews, MD 8001 Franklin Farms Dr, Suite 130, Richmond, VA 23229-5108 Ph: (804) 521-5800 | Dr Bradford James Matthews, MD 8700 Stony Point Pkwy Ste 120, Richmond, VA 23235-1965 Ph: (804) 323-5011 |
News Archive
An interest in solving complex problems, friends training to be medical doctors and his father having a stroke helped put John Asiruwa on the path to becoming a biomedical engineer.
Scientific research published in the current issue of the Journal of the American Medical Informatics Association (JAMIA) reports on a study of genetic variants that influence human susceptibility to peripheral arterial disease (PAD), made possible by leveraging electronic medical records (EMRs; also called EHRs or electronic health records).
Quest Diagnostics Incorporated, the world's leading cancer diagnostics company, today announced that its ColoVantage test has been approved by New York State's Department of Health for testing on samples of patients in the state. It is believed to be the first molecular colorectal cancer detection method that employs a venal blood specimen to be approved by the state.
A new DNA test may make it much simpler to identify patients at risk of malignant hyperthermia (MH)—a rare but life-threatening complication of exposure to common anesthetics reports the November issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
New research published in the Journal of Analytical Toxicology shows how fingerprint-based drug screening can not only screen for the presence, or absence, of four classes of drugs of abuse, but that the technology also works when used by UK coroners to detect drugs in the sweat of fingerprint samples gathered from deceased individuals.
› Verified 9 days ago
Dr. Amy Samantha May Paul, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1250 E Marshall St, Dept. Of Internal Medicine/geriatric Medicine, Richmond, VA 23298 Phone: 804-254-3500 Fax: 804-254-1616 | |
Dr. Clifton Linwood Parker, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 8300 Fulham Drive, Richmond, VA 23227 Phone: 804-264-5901 | |
Dr. Michael A Mistretta, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6600 W Broad St Ste 300, Richmond, VA 23230 Phone: 804-320-4243 Fax: 804-622-0552 | |
Patricia J Sime, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 9000 Stony Point Pkwy, Richmond, VA 23235 Phone: 804-560-8921 Fax: 804-560-8992 | |
Dr. Katherine Lavan Smallwood, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6900 Forest Ave, Suite 300, Richmond, VA 23230 Phone: 804-346-1515 Fax: 804-270-2888 | |
Walid G. Abou Assi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7605 Forest Ave, Suite 109, Richmond, VA 23229 Phone: 804-285-6390 Fax: 804-285-6393 | |
Dr. Paulina Essah, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 719 N 25th St, Richmond, VA 23223 Phone: 804-253-1963 Fax: 804-780-0862 |